216 results on '"Smock, Kristi J."'
Search Results
2. Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban: Results of the College of American Pathologists External Quality Assessment Program
3. Establishing reference intervals for von Willebrand factor multimers
4. Genotype and Phenotype Concordance for Pharmacogenetic Tests Through Proficiency Survey Testing: An Update
5. External Quality Assurance of Platelet Function Assays: Results of the College of American Pathologists Proficiency Testing Program
6. Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part 2
7. Von Willebrand factor testing ratios in the diagnosis and subtyping of von Willebrand disease
8. Pharmacogenetic Testing for Anticoagulant and Antiplatelet Therapies
9. Laboratory Assays for ADAMTS13
10. Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
11. Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part I
12. Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
13. Rare complication of treated immune thrombocytopenia
14. Issues Surrounding Age-Adjusted d-Dimer Cutoffs That Practicing Physicians Need to Know When Evaluating Patients With Suspected Pulmonary Embolism
15. Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer
16. Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
17. Direct oral anticoagulant (DOAC) interference in hemostasis assays
18. Cryptogenic oozers and bruisers
19. Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
20. Expression of Notch1 and mTOR pathway proteins in pediatric lymphoblastic lymphoma; a Children’s Oncology Group report
21. ADAMTS13 testing update: Focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies
22. Pharmacogenetic Testing for Anticoagulant and Antiplatelet Therapies
23. Vaccine‐induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism
24. The Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban: Results of the College of American Pathologists External Quality Assessment Program
25. Memorial notice: Elizabeth M. Van Cott MD
26. Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy
27. Proficiency Testing Results for Heparin-Induced Thrombocytopenia in North America
28. Factor XIII Assays and Associated Problems for Laboratory Diagnosis of Factor XIII Deficiency: An Analysis of International Proficiency Testing Results
29. Improvement of bleeding manifestations of acquired von Willebrand syndrome after balloon aortic valvoplasty in a child with aortic stenosis
30. Statistical Literacy Among Academic Pathologists: A Survey Study to Gauge Knowledge of Frequently Used Statistical Tests Among Trainees and Faculty
31. Reviewers
32. Laboratory testing for platelet antibodies
33. FACTOR XIII ASSAYS, A PROBLEM FOR LABORATORY DIAGNOSIS? AN ANALYSIS OF INTERNATIONAL PROFICIENCY TESTING RESULTS: 208
34. An Inherited Disorder With Splenomegaly, Cytopenias, and Vision Loss
35. Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods
36. Letter to the Editor on “The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria”
37. Patient advocacy and its importance to laboratory medicine practice
38. Polycythemia vera-associated acquired von Willebrand syndrome despite near-normal platelet count
39. Avoiding errors in the laboratory evaluation of potent lupus anticoagulants
40. Laboratory identification of lupus anticoagulants
41. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: A report from the Childrenʼs Oncology Group
42. What have we learned from coagulation laboratory participation in external quality programs?
43. Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis
44. External Quality Assurance of Platelet Function Assays: Results of the College of American Pathologists Proficiency Testing Program
45. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
46. Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part II.
47. Antiphospholipid antibody syndrome
48. Q&A.
49. Quantitation of plasma cells in bone marrow aspirates by flow cytometric analysis compared with morphologic assessment
50. Textbook Reviewers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.